Champions Oncology, Inc.
CSBR
$7.63
$0.222.97%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -140.82% | 517.45% | -44.55% | 1,304.59% | 95.69% |
| Total Depreciation and Amortization | -1.01% | -0.25% | -11.14% | -1.75% | -4.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.23% | 446.81% | -80.25% | -55.22% | 40.79% |
| Change in Net Operating Assets | 257.15% | -226.93% | 21.95% | 40.29% | -960.53% |
| Cash from Operations | 1,301.63% | 273.14% | -191.00% | 117.13% | -97.61% |
| Capital Expenditure | -502.38% | 55.32% | -- | -- | 103.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -502.38% | 55.32% | -- | -- | 103.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -2.70% | 0.00% | 2.63% | -11.76% |
| Issuance of Common Stock | -84.21% | -86.23% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 745.95% | 0.00% | -8.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,369.42% | 424.64% | -150.36% | 114.81% | -77.03% |